Avner Reshef

5.4k total citations
55 papers, 1.8k citations indexed

About

Avner Reshef is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Avner Reshef has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Genetics, 16 papers in Hematology and 14 papers in Immunology. Recurrent topics in Avner Reshef's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (42 papers), Hemophilia Treatment and Research (14 papers) and Vitamin K Research Studies (13 papers). Avner Reshef is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (42 papers), Hemophilia Treatment and Research (14 papers) and Vitamin K Research Studies (13 papers). Avner Reshef collaborates with scholars based in Israel, United States and Germany. Avner Reshef's co-authors include Timothy Craig, Dumitru Moldovan, Robyn J. Levy, Hilary Longhurst, Marco Cicardi, Teresa Caballero, Jonathan A. Bernstein, Anurag Relan, Marc A. Riedl and Krystyna Obtułowicz and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and The Journal of Pediatrics.

In The Last Decade

Avner Reshef

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avner Reshef Israel 22 1.3k 595 472 442 421 55 1.8k
Carmen Gelpí Spain 17 146 0.1× 381 0.6× 208 0.4× 51 0.1× 314 0.7× 53 1.1k
Jennifer Scafidi United States 9 593 0.4× 132 0.2× 278 0.6× 164 0.4× 141 0.3× 9 777
Y Niitsu Japan 10 291 0.2× 62 0.1× 141 0.3× 63 0.1× 46 0.1× 33 831
A. Mussi Italy 17 161 0.1× 307 0.5× 405 0.9× 6 0.0× 271 0.6× 33 804
Nobuki Maki Japan 13 53 0.0× 172 0.3× 189 0.4× 17 0.0× 136 0.3× 29 742
Devendra Hiwase Australia 20 489 0.4× 174 0.3× 172 0.4× 22 0.0× 80 0.2× 107 1.3k
U Kyan-Aung United Kingdom 8 41 0.0× 111 0.2× 472 1.0× 64 0.1× 29 0.1× 8 1.1k
Fabio Stagno Italy 26 717 0.5× 355 0.6× 202 0.4× 5 0.0× 118 0.3× 108 1.5k
Jean-Marie Jaspar Belgium 15 35 0.0× 397 0.7× 141 0.3× 22 0.0× 70 0.2× 17 847
Rosa Alba Rana Italy 17 484 0.4× 183 0.3× 214 0.5× 11 0.0× 16 0.0× 37 1.1k

Countries citing papers authored by Avner Reshef

Since Specialization
Citations

This map shows the geographic impact of Avner Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Reshef more than expected).

Fields of papers citing papers by Avner Reshef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Reshef. The network helps show where Avner Reshef may publish in the future.

Co-authorship network of co-authors of Avner Reshef

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Reshef. A scholar is included among the top collaborators of Avner Reshef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Reshef. Avner Reshef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farkas, Henriette, Jonny Peter, Marcin Stobiecki, et al.. (2025). Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema. Annals of Allergy Asthma & Immunology. 135(3). 311–319.e6. 1 indexed citations
2.
Craig, Timothy, Donald S. Levy, Avner Reshef, et al.. (2024). Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study. The Lancet Haematology. 11(6). e436–e447. 8 indexed citations
3.
Porębski, Grzegorz, Mateusz Kwitniewski, & Avner Reshef. (2021). Biomarkers in Hereditary Angioedema. Clinical Reviews in Allergy & Immunology. 60(3). 404–415. 15 indexed citations
4.
Golander, Hava, et al.. (2021). New Instrument for the Evaluation of Prodromes and Attacks of Hereditary Angioedema (HAE-EPA). Clinical Reviews in Allergy & Immunology. 61(1). 29–39. 2 indexed citations
5.
Levy, Donald S., Teresa Caballero, Iftikhar Hussaın, et al.. (2020). Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema. Pediatric Allergy Immunology and Pulmonology. 33(3). 136–141. 16 indexed citations
6.
Levy, Donald S., Henriette Farkas, Marc A. Riedl, et al.. (2020). Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma and Clinical Immunology. 16(1). 8–8. 14 indexed citations
7.
Stauber, Tali, Ramit Maoz‐Segal, Danit R. Shahar, et al.. (2018). A Structured Gradual Exposure Protocol to Baked and Heated Milk in the Treatment of Milk Allergy. The Journal of Pediatrics. 203. 204–209.e2. 13 indexed citations
8.
Farkas, Henriette, Avner Reshef, Werner Aberer, et al.. (2017). Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 5(6). 1671–1678.e2. 39 indexed citations
9.
Riedl, Marc A., Vesna Grivcheva‐Panovska, Dumitru Moldovan, et al.. (2017). Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. The Lancet. 390(10102). 1595–1602. 48 indexed citations
10.
Baker, James, et al.. (2017). Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. The Journal of Allergy and Clinical Immunology In Practice. 5(4). 1091–1097. 10 indexed citations
11.
Li, H. Henry, Dumitru Moldovan, Jonathan A. Bernstein, et al.. (2015). Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks. The Journal of Allergy and Clinical Immunology In Practice. 3(3). 417–423. 30 indexed citations
12.
Leiding, Jennifer W., Stephen C. Dreskin, Anete Sevciovic Grumach, et al.. (2014). Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions. World Allergy Organization Journal. 7(1). 2–2. 2 indexed citations
13.
Riedl, Marc A., Jonathan A. Bernstein, Henry Li, et al.. (2014). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 112(2). 163–169.e1. 60 indexed citations
14.
Lumry, William R., H. Henry Li, Robyn J. Levy, et al.. (2011). Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Annals of Allergy Asthma & Immunology. 107(6). 529–537.e2. 178 indexed citations
15.
Reshef, Avner, et al.. (2003). Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed Orthodox Jews. Clinical & Experimental Allergy. 33(7). 956–961. 122 indexed citations
16.
Bank, Ilan, et al.. (1998). Role of γ/δ T cells in a patient with CD4+ CD3– lymphocytosis, hypereosinophilia, and high levels of IgE. Journal of Allergy and Clinical Immunology. 102(4). 621–630. 20 indexed citations
17.
Tamir, Rami, et al.. (1997). Allergenicity of the pollen of Pistacia. Allergy. 52(3). 323–330. 8 indexed citations
18.
Reshef, Avner, Anne Kagey‐Sobotka, N ADKINSONJR, Lawrence M. Lichtenstein, & Philip S. Norman. (1989). The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). Journal of Allergy and Clinical Immunology. 84(5). 678–687. 32 indexed citations
19.
Weiner, P, et al.. (1988). Isotonic Nebulized Disodium Cromoglycate Provides Better Protection against Methacholine- and Exercise-induced Bronchoconstriction. American Review of Respiratory Disease. 137(6). 1309–1311. 8 indexed citations
20.
Warner, Jane A., Avner Reshef, & Donald W. MacGlashan. (1987). A rapid Percoll technique for the purification of human basophils. Journal of Immunological Methods. 105(1). 107–110. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Gelpí Breakdown of academic impact, for papers by Jennifer Scafidi Breakdown of academic impact, for papers by Y Niitsu Breakdown of academic impact, for papers by A. Mussi Breakdown of academic impact, for papers by Nobuki Maki Breakdown of academic impact, for papers by Devendra Hiwase Breakdown of academic impact, for papers by U Kyan-Aung Breakdown of academic impact, for papers by Fabio Stagno Breakdown of academic impact, for papers by Jean-Marie Jaspar Breakdown of academic impact, for papers by Rosa Alba Rana
Rankless by CCL
2026